1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Michel Giunta: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treat and Extend Analysis Trial With Aflibercept in Wet-AMD Aflibercept - Wet Age-related Macular Degeneration | Phase 3 | Unknown | Michel Giunta | 40 | 2019-07-24 | 2022-06-14 |
aflibercept (1)
Canada (1)